Renal anaphylaxis. I. Antigen-initiated responses from isolated perfused rat kidney  by Pirotzky, Eduardo et al.
Kidney International, Vol. 32 (1987), pp. 233—237
Renal anaphylaxis. I. Antigen-initiated responses from isolated
perfused rat kidney
EDUARDO PIROTZKY, GUILLEM PINTOS-MORELL, CLAUDE BURTIN, JANE BOUDET,
JOCELYNE BIDAULT, and JACQUES BENVENISTE
INSERM U.200, Université Paris—Sud, 32 rue des Carnets, 92140 Clamart, France
Renal anaphylaxis. L Antigen—initiated responses from isolated
perfused rat kidney. Isolated perfused rat kidneys were passively
sensitized by addition of either mouse ascitic fluid containing monoclo-
nal IgE against dinitrophenol (DNP) or DNP-specific purified IgE. After
washing the organ, defined doses of DNP-bovine serum albumin were
given as bolus injection via the kidney al-tery. Antigen challenge of
IgE-sensitized kidneys resulted in a dose—dependent increase of perfu-
sion pressure starting with 5 g antigen (2.46 0.2 mm Hg) and
reaching a maximum at dose higher than 100 g (10.3 1.6 mm Hg) (N
4, means I SD). A decrease of glomerular filtration rate was also
observed which reached a plateau at 100 g antigen (—68.5 2.9%) (N
= 4). Regardless of the dose of antigen used, the urinary protein
excretion markedly increased for the first five minutes following antigen
iijection and returned to basal values after 10 minutes. The total
amounts of histamine, POE2 and paf-acether (platelet—activating factor)
released upon antigen challenge (1 mg) for 15 minutes reached maximal
values of 405 21.1 ng, 286 19.4 pg and 12.3 3.2 ng (N = 5),
respectively. None of these hemodynamic and biochemical effects were
observed using IgG1 monoclonal antibodies or when the ascitic fluid
containing monoclonal IgE used to sensitize the organ was heated at
56°C for two hours. Thus, we have described a pure IgE-dependent rat
kidney anaphylaxis. Antigen challenge markedly altered renal parame-
ters and triggered the release of various mediators from the organ,
suggesting that type I-hypersensitivity reactions may play a role in renal
pathophysiology.
The occurrence of renal diseases mediated via IgE-dependent
mechanisms (type I-hypersensitivity reactions) has been re-
ported in both experimental animal models and man [1—4].
Indeed, in the rabbit, such mechanisms involving blood circu-
lating basophils have been shown to play a role in the deposition
of immune complexes during the development of acute serum
sickness [1, 2]. In addition, patients presenting with idiopathic
nephrotic syndrome (INS) exhibit a substantial increase in
serum IgE [5] as well as higher prevalence of IgE-basophil
sensitization to various allergens [6]. However, the develop-
ment of type I-hypersensitivity reactions at the renal level was
never directly demonstrated. The capability of IgE-sensitized
renal cells to release inflammatory mediators after antigen
challenge could strengthen the concept of renal anaphylaxis.
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Once sensitized with IgE antibodies various cell types are
capable of releasing mediators at the time of their challenge
with the specific antigen [7—10]. Among these mediators, the
preformed ones, that is, histamine and serotonin, as well as the
newly synthesized lipid mediators, such as prostaglandins (PG),
leukotrienes and paf-acether, might be instrumental in renal
diseases. Arachidonic acid derivatives exhibit inflammatory
properties including the ability to elicit plasma exudation and
vasoconstriction [11, 121. Paf-acether (platelet activating factor)
is a phospholipid mediator endowed with inflammatory and
anaphylactic effects such as platelet and neutrophil activation
and increased vascular and glomerular permeability. It is re-
leased from inflammatory and renal cells [13]. We have previ-
ously demonstrated the formation and release of inflammatory
mediators from rat kidney and isolated cells [14, 15]. Therefore
these mediators could play a major role in the vascular alter-
ations observed during renal diseases.
To investigate whether or not IgE-mediated reactions can
occur in isolated perfused rat kidney we studied the alterations
in physiological parameters as well as the release of inflamma-
tory mediators induced upon antigen challenge. In order to
overcome the difficulty in precisely defining the isotype of the
sensitizing antibody, we have developed a model where a
mouse monoclonal anti-DNP antibody of the IgE class is used
to passively sensitize rat kidney. This study demonstrates that
antigen stimulation of passively IgE-sensitized isolated rat
kidney induces an increase in perfusion pressure (PP), a de-
crease in glomerular filtration rate (GFR) and a transient
proteinuria (Pu) simultaneously with the release of histamine,
PGE2 and paf-acether.
Methods
Perfusion procedure
The perfusion apparatus and procedures were identical to
those described by Bowman and Maack [161 modified by
Nakane et a! [17]. Briefly, the apparatus is composed of a
central glass column containing Krebs buffer (mM concentra-
tions): NaCI, 11; NaHCO3, 20; Mg504, 0.12; KH2PO4, 10;
CaC12, 2.5; glucose, 5.5; supplemented with 0.25% bovine
serum albumin (K-BSA). The solution was gassed with 95% 02
and 5% CO2 and constantly recirculated via a pump (Cole—
Parmer, Chicago, Illinois, USA). Male Wistar rats (300 to 350 g)
were anesthetized with an intrapet-itoneal injection of sodium
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penthobarbital (Abbott, Chicago, Illinois, USA) (40 mg/kg).
Heparin (Roche, Neuilly s/Seine, France) (200 U) was injected
into the penis vein and a laparotomy was performed. The right
ureter was canulated with a polyethylene tube (I.D. 28 mm,
O.D. 61 mm) (Clay—Adams, Parsippary, New Jersey, USA).
The right renal artery was then canulated with a needle (0.8 to
38 mm) through the superior mesenteric artery and the kidney
was perfused in situ with K-BSA (25 ml at 37°C) at a hydrostatic
pressure of 120 cm. Thereafter the kidney was removed,
transferred into the central column and perfused with 100 ml of
K-BSA. The PP (expressed in mm Hg) was monitored via a
pressure transducer (Narco Bio-System, Houston, Texas,
USA) attached to the arterial cannula.
Sensitization with monoclonal IgE antibodies and antigen
challenge of isolated rat kidneys
Kidneys were passively sensitized upon addition to the
perfusion medium of 200 1.d of Balb/c mouse ascitic fluid
containing monoclonal IgE (hybridoma line 2682-1) directed
against dinitrophenol (DNP) with a passive cutaneous
anaphylaxis titer of 1/160,000, or DNP-specific IgE purified
from ascitic fluid (1 mg) [18]. To determine the specificity of the
reaction, heat—inactivated (56°C, 2 hr) ascitic fluid containing
monoclonal IgE or mouse ascitic fluid containing anti-DNP
monoclonal IgG1 were perfused in separate experiments. After
45 minutes perfusion, the organ was washed with 100 ml of
K-BSA, the kidneys were transferred into another "single
pass" column outside the central one and the perfusion was
continued with 100 ml of fresh K-BSA. Defined doses of
DNP.-BSA (1 g-1 mg) in 200 1.d K-BSA were then bolus
injected via the kidney artery. DNP-BSA antigen was prepared
according to [19] and stored at —20°C. The concentration of
DNP-BSA and the extent of substitution (DNP13-BSA) were
calculated using a molar extinction coefficient of DNP-L-lysine
of 17,530 at 360 nm [191. Fractions from venous effluent were
collected at 10 second intervals for five minutes using an
automated fraction collector (Isco, Lincoln, Nebraska, USA).
In some experiments, fractions were collected for 15 minutes.
Measurement of glomerular filtration rate (GFR) and
proteinuria (Pu)
To measure GFR, creatinine (Merck, Darmstadt, FRG) (15 to
20 mg/liter) was added to the K-BSA buffer. Creatinine was
measured in perfusate and in urinary samples collected for five
minute time intervals using a creatinine analyzer instrument
(Beckman Instruments, Inc. Galway, Ireland). GFR was ex-
pressed as p.l/minlg of contralateral kidney wet weight. Urinary
protein concentration was determined on samples collected for
five minutes using the method of Lowry et al [20] and expressed
as /Lg/min.
Sample preparation and mediator assays
Histamine, PGE2 and paf-acether were measured from the
venous effluent in fractions collected every 10 seconds for five
minutes. In different experiments, the total amounts of the
mediators released were measured in the effluent collected for
15 minutes after antigen challenge. To preserve histamine, 0.5
ml of perchloric acid (0.8 N) was added to 0.5 ml of perfusate for
one hour. The samples were then centrifuged (2800 g X is mm)
and the supernatants stored in polyethylene tubes at 4°C until
assay. Histamine was assayed by a modification of the
fluorometric method [21] adapted to an automated continuous
flow technique. Linear dose—response relationship was ob-
tained from 5 to 100 ng/ml of histamine—base. The presence of
DNP-BSA did not influence the histamine assay. PGE2 was
measured by radioimmunoassay (RIA) as described [22].
Paf-acether measurements were carried out after high pres-
sure liquid chromatography (HPLC) of the effluent collected for
15 minutes since paf-acether was never detected in the crude
perfusate after challenge with DNP-BSA. The samples were
added with 4 volumes of ethanol for one hour and centrifuged
for 10 minutes at 1000 x g. After evaporation, the residues were
recovered in chloroformlmethanol (1:1 vollvol) and resolved on
a HPLC apparatus (Waters Associates, Milford, Massachu-
setts, USA) using a Microporasil column, eluted with
dichloromethane/methanol/water (65:50:5, vol/vol) at a flow
rate of I mI/mm [23]. Sphingomyelin (Sigma Chemical Co, St
Louis, Missouri, USA), lyso-phosphatidylcholine (Sigma) and
synthetic 1-0-octadecyl-2-acetyl-sn-glycero-3-phosphocholine
(Bachem, Bubendorf, Switzerland) were used as standards in
the HPLC procedure. Fractions collected every minute were
dried under an air stream, recovered in 0.2 ml of RPMI-BSA
and bioassayed by platelet aggregation according to [24].
Briefly, rabbit platelets were prepared by differential centrifu-
gation and treated with 0.1 m aspirin for 15 minutes at room
temperature to avoid aggregation due to contaminating arachi-
donic acid. Aggregation was carried out in the presence of the
ADP scavenger complex creatine phosphate (1 mM)/creatine
phosphokinase (10 U/mI). Paf-acether content in the samples
was measured over the linear portion of a calibration curve
obtained with 5 to 40 pg of synthetic paf-acether and was
expressed in equivalent of synthetic paf-acether. Besides its
typical retention time in HPLC, paf-acether was characterized
by the loss of its aggregating activity upon incubation with 10
jsg/ml of phospholipase A2 from hog pancreas (Boehringer
Mannheim, GFR) and its insensitivity to 100 jsg/ml of lipase
from Rhizopus arrhizus (Boehringer) as previously described
[25],
Statistics
The results are given as means 1 SD. Significance was
calculated using the Student's paired t-test.
Results
Alteration in physiological parameters after antigen challenge
of IgE-passively sensitized kidneys
Intraarterial injection of DNP-BSA to IgE-sensitized kidney
caused a marked alteration in PP (Fig. 1, Table 1). The increase
in PP was preceded by a lag period of about one minute,
reached a maximum at two minutes and returned to basal levels
after four minutes. The extent of PP increase, as well as of the
lag period and time of recovery depended upon the dose of the
antigen used for the challenge (Table 1). No variation in PP was
observed when 2.5 p.g DNP-BSA were used. For doses of
antigen above 5 g, PP increased in a dose—dependent fashion
up to a maximum reached at 100 pg of DNP-BSA. Using high
doses of the antigen shortened the lag period and markedly
prolonged the phenomenon, since the return to baseline values
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Fig. 1. PP increase induced by intraarterial bolus injection of 50 ig
DNP-BSA to IgE-sensitized kidney. The arrow indicates the time of
bolus injection (one experiment representative of 4).
was observed only after nine minutes when 100 tg DNP-BSA
were used.
The basal value of GFR during the sensitization period was
404.5 pi/min/g (range 269.2 to 577.3). A dose—dependent de-
crease of GFR was observed during the first five minutes after
DNP-BSA injection (Table 1). A marked decrease of GFR
already occurred at 25 tg DNP-BSA and reached plateau
values at 100 g. GRF returned to normal values 10 minutes
after injection of 25 or 50 g antigen and at 15 minutes after
injection of 100 g (data not shown). In four experiments the
average basal Pu was 28.2 g/min (range 21.8 to 35.1). Pu
increased when doses higher than 5 tg DNP-BSA were injected
(Table 2). At 50 g DNP-BSA, Pu was 52.8 5.3 gImin at five
minutes, which was significantly different from basal values (P
<0.01, N = 4). The increase in Pu was maximal over the five
first minutes. Depending upon the dose of DNP-BSA used, Pu
returned to basal values within 10 to 15 minutes.
In three experiments with kidneys sensitized with purified
IgE and challenged with 100 g DNP-BSA, PP increased 11.4
1.9 mm Hg and GFR decreased by 71.3 38.0%.
Mediator release
The time— and dose—dependency of the release of histamine
after antigen challenge is shown in Figure 2. Histamine release
began 20 seconds after DNP-BSA injection and a peak was
observed at 40 to 50 seconds. The amount of histamine as well
as the duration of the release increased from 5 to 50 g
DNP-BSA.
In contrast with histamine, PGE2 and paf-acether could not
be directly measured in the eluate from antigen—stimulated
IgE-sensitized kidneys, but only after extraction of the pooled
perfusate collected for 15 minutes. In five experiments, the total
amounts of histamine, PGE2 and paf-acether generated after
DNP-BSA challenge were compared (Table 3). The release of
histamine and PGE2 was dose—dependent, starting with doses
of antigen of 5 and 25 g, respectively, and reaching a maxi-
mum at 100 g. In contrast, the release of paf-acether was only
observed after bolus injection of 100 ig and 1000 g DNP-BSA.
In three experiments with kidneys sensitized with purified IgE
and challenged with 100 g DNP-BSA, 415 25.8 ng, 292
28.4 pg and 6.3 2.8 ng of histamine, PGE2 and paf-acether,
respectively, were recovered from the effluent collected for 15
minutes. At the end of each experiment a second injection of
DNP-BSA was given. No release of mediators or alteration in
physiological parameters were detected.
Neither release of mediators nor physiological changes were
observed when sensitized kidneys were stimulated with BSA or
upon challenge with DNP-BSA of either unsensitized kidneys
or kidneys sensitized with heat—inactivated IgE or with mono-
clonal IgG1 antibodies.
Discussion
After passive sensitization with monoclonal IgE and chal-
lenge with the specific antigen, isolated perfused rat kidneys
exhibited immediate type hypersensitivity responses. The
anaphylactic reaction was evidenced by pathophysiological
changes and the release of inflammatory mediators. This obser-
vation is suggestive of the presence of IgE receptors in renal
cells, since the organs were extensively washed before and after
passive sensitization in order to exclude the participation of
blood cells in the response to the antigen. In addition, in a
previous report, the absence of circulating cells in the isolated
perfused kidneys was confirmed by electron microscopy [14].
The specificity of the IgE response was highly probable since
perfusing antibodies heated at 56°C for two hours failed to
sensitize the organ. Also, the release of mediators as well as the
physiological alterations exhibited tachyphylaxis to a second
DNP-BSA challenge, which is a characteristic feature of
anaphylactic response.
Antigen challenge of passively sensitized kidneys induced
marked and transient alterations in PP, GFR and Pu since it
caused a dose—dependent increase in PP and Pu and a decrease
of GFR. These alterations are frequently seen in various kidney
diseases either in man or animals. The occurrence of such
alterations suggests that mediators could be released from
IgE-bearing cells. Indeed, histamine, PGE2 and paf-acether
were present in the venous effluent after kidney challenge with
the antigen. The difference between antigen dose—response and
time—course for mediator release suggests that they may arise
from different IgE-sensitized renal cell types. The renal cell
subpopulation(s) implicated in the IgE responses were not
determined in the present study. However, the participation of
glomerular cells including mesangial, epithelial and endothelial
cells must be envisioned since they are known to release
histamine, PGE2 and paf-acether [15, 26—28].
In the present study the relationship between vascular re-
sponses and release of histamine, PGE2 and paf-acether was not
determined. However, most of the alterations in renal parame-
ters can be explained on the basis of the recognized biological
activities of these mediators. Histamine is known to contract
smooth muscle and to increase vascular permeability. In addi-
tion, histamine induces renal vasodilatation after injection in
dogs [29]. The increase of PP that we observed indicates that
vasoconstrjction of renal vessels occurred after antigen chal-
lenge. Therefore PGE2 which is produced by the nephron [12]
and is known to produce vasoconstriction or vasodilatation in
isolated rat kidney [30] could, rather than histamine, play a role
in the increase in PP. This is supported by experiments showing
that antigen stimulation of kidney pretreated with indomethacin
induced a lesser increase of PP as compared to untreated rat
kidney (G. Pintos—Morell et al, in preparation). These results
suggest that cyclooxygenase—dependent arachidonate metabo-
lites can participate in the tone regulation of the renal
vasculature during anaphylactic reaction in isolated kidney.
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Table 1. Dose—dependent alterations of PP and GFR induced by DNP-BSA in IgE-sensitized rat kidney
DNP-BSA
pg
Alterations of PP
GFR decrease
%
Lag period
sec
Maximal increase
mmHg
Time of recovery
mm
2.5
5
25
50
100
2000
NA'
65.0 1.0
59.6 1.5
55.6 3.5
42.0 1.2
40.3 1.5
0
2.4 0.2
4.6 0,3b
7.8 0,2"
10.3 1.6'
10.9 1.0'
NA
3.5 0.3
4.4 0.2
5.3 0.1
9.2 0.4
9.3 0.3
0
0
11.4 0.8
43.4 3.0"
68.6 2.9'
68.8 2.4'
Results are expressed as means I su of four experiments. GFR was measured over a five minute period after DNP-BSA injection.
a NA, not applicable
b P < 0.05
P < 0.01
DNP-BSA
pg
Histamine
ng
PGE2
pg
Paf-acether
ng
5 55.2±7.2 0 0
25 149.0 24.4 93.6 12.1 0
50 290.0 59.6 118.0 11.3 0
100 391.0 22.3 274.0 22.3 4.5 2.1
1000 405.0 21.2 286.0 19.4 12.3 3.2
[34]. All these results suggest that this mediator could influence
the kidney vasculature following antigen challenge.
Our results show that glomerular permeability assessed by an
increase of Pu was augmented after antigen stimulation. These
findings are consistent with some in vivo reports. Indeed, it was
reported that Pu worsened in six children with nephrotic
syndrome after they ingested cow's milk [35] and, in three
cases, sensitization to grass pollen was associated with seasonal
proteinuria [36]. Our data suggest that IgE-hypersensitivity
mechanism mediated directly through kidney cells could be
responsible for Pu. Histamine, PGE2 and paf-acether are capa-
ble of increasing vascular permeability [37—39] and protein
leakage. However, the in vivo increase in vascular permeability
may result from the release of mediators not only from sensi-
tized kidney cells but also from basophil and other IgE-bearing
cell types. A possible role for degranulation of sensitized
basophils was previously reported in nephrotic patients [61 and
in rabbit serum sickness [1, 2], suggesting the implication of
anaphylactic processes in renal diseases. Although the present
study demonstrates that isolated perfused kidney exhibit
anaphylactic reaction per Se, further studies are needed to
localize the IgE-bearing cells and to determine the involvement
of such reaction in in vivo models and in man.
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